Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Non-Current Assets (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Other Non-Current Assets for 13 consecutive years, with $152000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $152000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $152000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $152000.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets for Q4 2025 was $152000.0 at Niagen Bioscience, roughly flat from $152000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $458000.0 in Q1 2025, with the low at $152000.0 in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $187150.0, with a median of $152000.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Assets dropped 24.0% in 2021, then soared 201.32% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $152000.0 in 2021, then changed by 0.0% to $152000.0 in 2022, then changed by 0.0% to $152000.0 in 2023, then changed by 0.0% to $152000.0 in 2024, then changed by 0.0% to $152000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $152000.0, $152000.0, and $405000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.